Compounds > uridine 5'-(alpha-d-apio-d-furanosyl pyrophosphate)
Page last updated: 2024-12-08
uridine 5'-(alpha-d-apio-d-furanosyl pyrophosphate)
Description
UDP-alpha-D-apiose : A UDP-D-apiose in which the anomeric centre of the apiose fragment has alpha-configuration. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
UDP-D-apiose : A UDP-sugar having D-apiose as the sugar portion. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
Cross-References
ID Source | ID |
PubMed CID | 439536 |
CHEBI ID | 73886 |
MeSH ID | M0047340 |
Synonyms (12)
Synonym |
udp-alpha-d-apiose |
udp-d-apiose |
C01623 |
udp-apiose , |
20230-91-5 |
[(2r,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl] [[(2r,3s,4r,5r)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] hydrogen phosphate |
5'-o-[{[{[(2r,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)tetrahydrofuran-2-yl]oxy}(hydroxy)phosphoryl]oxy}(hydroxy)phosphoryl]uridine |
uridine 5'-{3-[3-c-(hydroxymethyl)-alpha-d-erythrofuranosyl] dihydrogen diphosphate} |
CHEBI:73886 |
uridine 5'-(trihydrogen diphosphate), mono-d-apio-d-furanosyl ester |
uridine 5'-(alpha-d-apio-d-furanosyl pyrophosphate) |
Q27144210 |
Drug Classes (1)
Class | Description |
UDP-D-apiose | A UDP-sugar having D-apiose as the sugar portion. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Research
Studies (12)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 2 (16.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (16.67) | 29.6817 |
2010's | 6 (50.00) | 24.3611 |
2020's | 2 (16.67) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.36
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 12.36 (24.57) | Research Supply Index | 2.56 (2.92) | Research Growth Index | 4.92 (4.65) | Search Engine Demand Index | 0.00 (26.88) | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 12 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |